$39.14
-0.31%Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.
Chief Executive Officer, President & Director
Compensation
$766,103
Chief Financial Officer, Executive Vice President & Director
Compensation
$684,317
Executive Vice President of Sales & Operations
Compensation
$681,050
Head of Investor Relations & Senior Director
President of East Tennessee Pharmacy Services
President of Guardian Pharmacy of Daytona
President of Right Dose Pharmacy - Iowa
Vice President & General Counsel
Vice President of Human Resources
Vice President of Technology & Senior Security Officer
During the last 12 months, insiders have purchased $100K and sold $305.09M worth of GRDN shares, resulting in $304.99M of net selling activity.
0
0.00
10.3M
305.09M
-305.1M
-$305.09M
0
0.00
0
0.00
+0
+$0
3.4K
99.78K
0
0.00
+100K
+$100K
0
0.00
0
0.00
+0
+$0
Cosler Steven D
Director
$100K
Salentine Thomas J Jr
Director, 10 Percent Owner:
$105.99M
Bindley Capital Partners I, Llc
10 Percent Owner
$105.99M
Pharmacy Investors, Llc
Other: Member Of 10% Owner Group
$24.57M
Ackerman John
Director
$24.57M
Burke Fred
Director, Officer: See Remarks
$19.93M
Strong bearish signal with $304.99M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
5 insider sellers vs. 1 buyers. Widespread selling across multiple insiders may signal concerns.
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
GRDN - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | March 26, 2026 | May 05, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | March 28, 2025 | May 09, 2025 | 2025 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.